Dynavax Technologies Corp. (DVAX)
10.96
-0.01
(-0.09%)
USD |
NASDAQ |
Dec 04, 16:00
10.96
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Market Cap: 1.287B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 307.30M |
| ADMA Biologics, Inc. | 4.786B |
| Aldeyra Therapeutics, Inc. | 293.59M |
| ACADIA Pharmaceuticals, Inc. | 4.492B |
| Amgen, Inc. | 183.17B |
Market Cap Related Metrics
| PS Ratio | 4.582 |
| Price to Book Value | 2.409 |
| Price to Free Cash Flow | 18.80 |
| Price | 10.96 |
| Earnings Yield | -3.48% |
| Operating PE Ratio | 145.09 |
| Normalized PE Ratio | 139.97 |